Robert Anderson, MD
Vascular Surgery · Kansas City, MONPI 1588656243
Payments from drug & device makers
What this record shows
This record is dominated by education: $19,387 of the $22,957 with a category attached, or 84.4%. Angiodynamics, Inc. accounts for 94.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $9,600 and has fallen 98.8% since, to $111 in 2025.
Across 22 payments — averaging $1043.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$22K
- Medtronic$643
- Tactile Systems Technology Inc$376
- Amgen$125
- Supernus Pharmaceuticals, Inc.$26
What the payments were for
- Food & beverage$1,1705%
- Education$19,38784%
- Other$2,40010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 6 | $21,787 |
| Medtronic(2 entities) | 8 | $643 |
| Tactile Systems Technology Inc | 6 | $376 |
| Amgen | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVLT$16,987
- VenaCure 1470 Pro$4,800
- COBALT DR MRI SURESCAN$310
- Flexitouch Plus$235
- Repatha$125
- Entre Plus$124
- Nimbl$111
How this compares
$22,957 in reported general payments places this provider in the 80th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,722 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Kansas City
- Robert CarterKansas City$48K
- Peter LauKansas City$23K
- Karthik VamananKansas City$7K
- Garrett TibbetsKansas City$7K
- Jamal MalikKansas City$4K
- Jeffrey JimSaint Louis$1.2M
- Karl StarkNorth Kansas City$223K
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.